475 related articles for article (PubMed ID: 19358976)
1. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.
Profenno LA; Porsteinsson AP; Faraone SV
Biol Psychiatry; 2010 Mar; 67(6):505-12. PubMed ID: 19358976
[TBL] [Abstract][Full Text] [Related]
2. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
Zubenko GS; Hughes HB; Stiffler JS
Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
[TBL] [Abstract][Full Text] [Related]
3. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease.
Xu W; Qiu C; Winblad B; Fratiglioni L
Diabetes; 2007 Jan; 56(1):211-6. PubMed ID: 17192484
[TBL] [Abstract][Full Text] [Related]
4. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.
Anstey KJ; Cherbuin N; Budge M; Young J
Obes Rev; 2011 May; 12(5):e426-37. PubMed ID: 21348917
[TBL] [Abstract][Full Text] [Related]
5. An 18-year follow-up of overweight and risk of Alzheimer disease.
Gustafson D; Rothenberg E; Blennow K; Steen B; Skoog I
Arch Intern Med; 2003 Jul; 163(13):1524-8. PubMed ID: 12860573
[TBL] [Abstract][Full Text] [Related]
6. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
9. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
10. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.
Kivipelto M; Ngandu T; Fratiglioni L; Viitanen M; Kåreholt I; Winblad B; Helkala EL; Tuomilehto J; Soininen H; Nissinen A
Arch Neurol; 2005 Oct; 62(10):1556-60. PubMed ID: 16216938
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC;
Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
[TBL] [Abstract][Full Text] [Related]
13. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
[TBL] [Abstract][Full Text] [Related]
14. Genetics, obesity, and environmental risk factors associated with type 2 diabetes.
Bener A; Zirie M; Al-Rikabi A
Croat Med J; 2005 Apr; 46(2):302-7. PubMed ID: 15849854
[TBL] [Abstract][Full Text] [Related]
15. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.
Gupta R; Sarna M; Thanvi J; Rastogi P; Kaul V; Gupta VP
Indian Heart J; 2004; 56(6):646-52. PubMed ID: 15751521
[TBL] [Abstract][Full Text] [Related]
18. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
19. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
20. The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis.
Ikram MA; Liu F; Oostra BA; Hofman A; van Duijn CM; Breteler MM
Biol Psychiatry; 2009 Jun; 65(11):995-9. PubMed ID: 19118819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
